Skip to main content

BORTEZOMIB

NDC 55150-337 · Eugia US LLC

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameBORTEZOMIB
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)BORTEZOMIB
Strength3.5 mg/1
Pharmacologic classProteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
Marketing categoryANDA

Packages

55150-337-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

55150-337-02 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J9041 — Injection, bortezomib, 0.1 mg Medicare Part B payment limit (ASP + 6%): $2.63

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9098 — bortezomib, 0409-1700 — Bortezomib, 0409-1703 — BORTEZOMIB, 0409-1704 — BORTEZOMIB, 25021-262 — BORTEZOMIB, 31722-303 — Bortezomib, 43598-426 — Bortezomib, 51817-586 — bortezomib, 60505-6050 — bortezomib, 63020-049 — bortezomib, 63323-821 — Bortezomib, 63759-3032 — Bortezomib, 67184-0530 — Bortezomib, 68001-534 — Bortezomib, 68001-540 — Bortezomib, 68001-541 — Bortezomib, 68083-650 — Bortezomib, 68083-651 — Bortezomib, 70069-836 — bortezomib, 70121-2484 — Bortezomib, +11 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources